Current understanding on TREM-2 molecular biology and physiopathological functions
International Immunopharmacology · 2024-06 · 134 · 112042
DOI: 10.1016/j.intimp.2024.112042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Shiv Bharadwaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Průmyslová 595, 252 50 Vestec,…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Membrane Glycoproteins. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 366 Literaturangaben. Gefördert von: Institute of Botany of the Czech Academy of Sciences.
Abstract (Originalsprache)
Triggering receptor expressed on myeloid cells 2 (TREM-2), a glycosylated receptor belonging to the immunoglobin superfamily and especially expressed in the myeloid cell lineage, is frequently explained as a reminiscent receptor for both adaptive and innate immunity regulation. TREM-2 is also acknowledged to influence NK cell differentiation via the PI3K and PLCγ signaling pathways, as well as the partial activation or direct inhibition of T cells. Additionally, TREM-2 overexpression is substantially linked to cell-specific functions, such as enhanced phagocytosis, reduced toll-like receptor (TLR)-mediated inflammatory cytokine production, increased transcription of anti-inflammatory cytokines, and reshaped T cell function. Whereas TREM-2-deficient cells exhibit diminished phagocytic function and enhanced proinflammatory cytokines production, proceeding to inflammatory injuries and an immunosuppressive environment for disease progression. Despite the growing literature supporting TREM-2+ cells in various diseases, such as neurodegenerative disorders and cancer, substantial facets of TREM-2-mediated signaling remain inadequately understood relevant to pathophysiology conditions. In this direction, herein, we have summarized the current knowledge on TREM-2 biology and cell-specific TREM-2 expression, particularly in the modulation of pivotal TREM-2-dependent functions under physiopathological conditions. Furthermore, molecular regulation and generic biological relevance of TREM-2 are also discussed, which might provide an alternative approach for preventing or reducing TREM-2-associated deformities. At last, we discussed the TREM-2 function in supporting an immunosuppressive cancer environment and as a potential drug target for cancer immunotherapy. Hence, summarized knowledge of TREM-2 might provide a window to overcome challenges in clinically effective therapies for TREM-2-induced diseases in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. Electronic address: shiv.bharadwaj@ibt.cas.cz.
- Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic.
- Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. Electronic address: petr.maly@ibt.cas.cz.
Förderung
- Institute of Botany of the Czech Academy of Sciences
Zitieren
APA
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024). Current understanding on TREM-2 molecular biology and physiopathological functions. International Immunopharmacology, 134, 112042. https://doi.org/10.1016/j.intimp.2024.112042
Vancouver
Bharadwaj S, Groza Y, Mierzwicka JM, Malý P. Current understanding on TREM-2 molecular biology and physiopathological functions. International Immunopharmacology. 2024;134:112042. doi:10.1016/j.intimp.2024.112042
BibTeX
@article{Bharadwaj2024,
author = {Bharadwaj, Shiv and Groza, Yaroslava and Mierzwicka, Joanna M and Malý, Petr},
title = {Current understanding on TREM-2 molecular biology and physiopathological functions},
journal = {International Immunopharmacology},
year = {2024},
volume = {134},
pages = {112042},
doi = {10.1016/j.intimp.2024.112042}
}
EUVIMED